Firstly, since most of the patients (n = 153) were enrolled before June 2021, we did not include those who harbored EZHIP overexpression, which also results in a global reduction of H3K27me3 according to the 5th edition of the WHO Classification of CNS Tumors. This evidence concerns the gene EZHIP and central nervous system neoplasm.